Improving pharmacovigilance in Europe

BMJ (Online)

Volumn 340, Issue 7751, 2010, Pages 821-

  Moore, Nicholas ^a   Bégaud, Bernard ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG EXPOSURE; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EUROPE; HOSPITAL ADMISSION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; EUROPEAN UNION; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS;

EID: 77951074523     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1694     Document Type: Editorial

References (11)

1. Herxheimer A. Communicating with patients about harms and risks. PLoS Med 2005;2:e42.[CrossRef] [Medline]
2. Godlee F, Chalmers I. Publishing information about ongoing clinical trials for patients. BMJ 2010;340:c725.[Free Full Text]
3. Garattini S, Bertele V. Europe's opportunity to open up drug regulation. BMJ 2010;340:c1578.[Free Full Text]
4. Miller JD. Registering clinical trial results: the next step. JAMA 2010;303:773-774[Free Full Text]
5. Kummerer K, Velo G. Ecopharmacology: a new topic of importance in pharmacovigilance. Drug Saf 2006;29:371-373[CrossRef][Web of Science][Medline] (Pubitemid 43752539)
6. Waller PC, Evans SJ, Beard K. Drug safety and regulation. BMJ 2005;331:4-5.[Free Full Text]
7. Commission of the European Communities. Proposal for a regulation of the European Parliament and of the council amending, as regards pharmacovigilance of medicinal products for human use. Regulation (EC) No 726/2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. COM (2008) 664. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0664: FIN:en:PDF.
8. Commission of the European Communities. Proposal for a directive of the European Parliament and of the council amending, as regards pharmacovigilance. Directive 2001/83/EC on the community code relating to medicinal products for human use. COM (2008) 665. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=COM:2008:0665:FIN:en:PDF.
9. Waller P, Beard K, Egberts T, Evans S, Hallas J, Hasford J, et al. European commission consultation on pharmacovigilance. Pharmacoepidemiol Drug Saf 2008;17:108-109[CrossRef][Web of Science][Medline]
10. Joint position: EU Commission's proposals on pharmacovigilance dismantle the entire system. 2009. www.dialogosuifarmaci.it/documents/En-CEProposals- June2009.pdf.
11. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19 [Abstract/Free Full Text] (Pubitemid 38869995)